Oncogene - Table of Contents alert Volume 32 Issue 24

Advertisement Finally! Antibodies you can trust. Diagenode has revolutionized immunoprecipitation with a novel, rigorous antibody validation system. We are the only company that partners with epigenetics experts including the BLUEPRINT consortium to develop the absolute best epigenetics reagents and antibodies with the highest specificity and sensitivity. Achieve unparalleled MeDIP, ChIP, and ChIP-seq results with antibodies you can trust. Learn more. TABLE OF CONTENTS Volume 32, Issue 24 (June 2013) In this issue Review Original Articles Short Communication Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Choose Scientific Reports for fast, efficient, open access publishing  93% of authors said they are likely or very likely to recommend Scientific Reports to their colleagues* 92% of authors would publish in Scientific Reports again*  SUBMIT your paper today!  *Nature Publishing Group author survey, data correct as of April 2013 Review Top Far upstream element binding protein 1: a commander of transcription, translation and beyond J Zhang and Q M Chen Oncogene 2013 32: 2907-2916; advance online publication, August 27, 2012; 10.1038/onc.2012.350 Abstract | Full Text Original Articles Top RSK regulates activated BRAF signalling to mTORC1 and promotes melanoma growth Y Romeo, J Moreau, P-J Zindy, M Saba-El-Leil, G Lavoie, F Dandachi, M Baptissart, K L B Borden, S Meloche and P P Roux Oncogene 2013 32: 2917-2926; advance online publication, July 16, 2012; 10.1038/onc.2012.312 Abstract | Full Text Modulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAs S Das, K Bryan, P G Buckley, O Piskareva, I M Bray, N Foley, J Ryan, J Lynch, L Creevey, J Fay, S Prenter, J Koster, P van Sluis, R Versteeg, A Eggert, J H Schulte, A Schramm, P Mestdagh, J Vandesompele, F Speleman and R L Stallings Oncogene 2013 32: 2927-2936; advance online publication, July 16, 2012; 10.1038/onc.2012.311 Abstract | Full Text E2F1 loss induces spontaneous tumour development in Rb-deficient epidermis C Costa, M Santos, M Martínez-Fernández, M Dueñas, C Lorz, R García-Escudero and J M Paramio Oncogene 2013 32: 2937-2951; advance online publication, August 13, 2012; 10.1038/onc.2012.316 Abstract | Full Text Elevated PLGF contributes to small-cell lung cancer brain metastasis B Li, C Wang, Y Zhang, X Y Zhao, B Huang, P F Wu, Q Li, H Li, Y S Liu, L Y Cao, W M Dai, W G Fang, D S Shang, L Cao, W D Zhao and Y H Chen Oncogene 2013 32: 2952-2962; advance online publication, July 16, 2012; 10.1038/onc.2012.313 Abstract | Full Text DNA damage-induced centrosome amplification occurs via excessive formation of centriolar satellites H Löffler, A Fechter, F Y Liu, S Poppelreuther and A Krämer Oncogene 2013 32: 2963-2972; advance online publication, July 23, 2012; 10.1038/onc.2012.310 Abstract | Full Text Plk1 is upregulated in androgen-insensitive prostate cancer cells and its inhibition leads to necroptosis A Deeraksa, J Pan, Y Sha, X-D Liu, N T Eissa, S-H Lin and L-y Yu-Lee Oncogene 2013 32: 2973-2983; advance online publication, August 13, 2012; 10.1038/onc.2012.309 Abstract | Full Text MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression M Kappelmann, S Kuphal, G Meister, L Vardimon and A-K Bosserhoff Oncogene 2013 32: 2984-2991; advance online publication, July 16, 2012; 10.1038/onc.2012.307 Abstract | Full Text Mutant p53 drives invasion in breast tumors through up-regulation of miR-155 P M Neilsen, J E Noll, S Mattiske, C P Bracken, P A Gregory, R B Schulz, S P Lim, R Kumar, R J Suetani, G J Goodall and D F Callen Oncogene 2013 32: 2992-3000; advance online publication, July 16, 2012; 10.1038/onc.2012.305 Abstract | Full Text Short Communication Top Forced activation of Cdk1 via wee1 inhibition impairs homologous recombination M Krajewska, A M Heijink, Y J W M Bisselink, R I Seinstra, H H W Silljé, E G E de Vries and M A T M van Vugt Oncogene 2013 32: 3001-3008; advance online publication, July 16, 2012; 10.1038/onc.2012.296 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.